FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2561872017> ?p ?o ?g. }

• W2561872017 endingPage "2960" @default.
• W2561872017 startingPage "2951" @default.
• W2561872017 abstract "Abstract Purpose: Human neural stem cells (NSC) are inherently tumor tropic, making them attractive drug delivery vehicles. Toward this goal, we retrovirally transduced an immortalized, clonal NSC line to stably express cytosine deaminase (HB1.F3.CD.C21; CD-NSCs), which converts the prodrug 5-fluorocytosine (5-FC) to 5-fluorouracil (5-FU). Experimental Design: Recurrent high-grade glioma patients underwent intracranial administration of CD-NSCs during tumor resection or biopsy. Four days later, patients began taking oral 5-FC every 6 hours for 7 days. Study treatment was given only once. A standard 3 + 3 dose escalation schema was used to increase doses of CD-NSCs from 1 × 107 to 5 × 107 and 5-FC from 75 to 150 mg/kg/day. Intracerebral microdialysis was performed to measure brain levels of 5-FC and 5-FU. Serial blood samples were obtained to assess systemic drug concentrations as well as to perform immunologic correlative studies. Results: Fifteen patients underwent study treatment. We saw no dose-limiting toxicity (DLT) due to the CD-NSCs. There was 1 DLT (grade 3 transaminitis) possibly related to 5-FC. We did not see development of anti-CD-NSC antibodies and did not detect CD-NSCs or replication-competent retrovirus in the systemic circulation. Intracerebral microdialysis revealed that CD-NSCs produced 5-FU locally in the brain in a 5-FC dose-dependent manner. Autopsy data indicate that CD-NSCs migrated to distant tumor sites and were nontumorigenic. Conclusions: Collectively, our results from this first-in-human study demonstrate initial safety and proof of concept regarding the ability of NSCs to target brain tumors and locally produce chemotherapy. Clin Cancer Res; 23(12); 2951–60. ©2016 AACR." @default.
• W2561872017 created "2017-01-06" @default.
• W2561872017 creator A5014173403 @default.
• W2561872017 creator A5018750805 @default.
• W2561872017 creator A5023082531 @default.
• W2561872017 creator A5037882003 @default.
• W2561872017 creator A5041131679 @default.
• W2561872017 creator A5042684673 @default.
• W2561872017 creator A5044330314 @default.
• W2561872017 creator A5048050785 @default.
• W2561872017 creator A5062213825 @default.
• W2561872017 creator A5068645990 @default.
• W2561872017 creator A5080598896 @default.
• W2561872017 creator A5081967247 @default.
• W2561872017 creator A5082853715 @default.
• W2561872017 creator A5088012470 @default.
• W2561872017 date "2017-06-14" @default.
• W2561872017 modified "2023-10-13" @default.
• W2561872017 title "Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients" @default.
• W2561872017 cites W1570839422 @default.
• W2561872017 cites W1972923489 @default.
• W2561872017 cites W1977934887 @default.
• W2561872017 cites W1980441719 @default.
• W2561872017 cites W1984400293 @default.
• W2561872017 cites W1986752046 @default.
• W2561872017 cites W1994410395 @default.
• W2561872017 cites W1995049782 @default.
• W2561872017 cites W2000929915 @default.
• W2561872017 cites W2003327408 @default.
• W2561872017 cites W2014475188 @default.
• W2561872017 cites W2016658377 @default.
• W2561872017 cites W2017593380 @default.
• W2561872017 cites W2028275643 @default.
• W2561872017 cites W2034074846 @default.
• W2561872017 cites W2045161060 @default.
• W2561872017 cites W2050100184 @default.
• W2561872017 cites W2061904165 @default.
• W2561872017 cites W2066517496 @default.
• W2561872017 cites W2068550415 @default.
• W2561872017 cites W2072246632 @default.
• W2561872017 cites W2073151094 @default.
• W2561872017 cites W2085377296 @default.
• W2561872017 cites W2090841339 @default.
• W2561872017 cites W2091166057 @default.
• W2561872017 cites W2092569492 @default.
• W2561872017 cites W2096338956 @default.
• W2561872017 cites W2099886521 @default.
• W2561872017 cites W2110347501 @default.
• W2561872017 cites W2115423266 @default.
• W2561872017 cites W2119242698 @default.
• W2561872017 cites W2121699071 @default.
• W2561872017 cites W2123531430 @default.
• W2561872017 cites W2126551611 @default.
• W2561872017 cites W2127771136 @default.
• W2561872017 cites W2134466068 @default.
• W2561872017 cites W2137703931 @default.
• W2561872017 cites W2143041108 @default.
• W2561872017 cites W2143554919 @default.
• W2561872017 cites W2143935367 @default.
• W2561872017 cites W2144500288 @default.
• W2561872017 cites W2146391063 @default.
• W2561872017 cites W2148278891 @default.
• W2561872017 cites W2162957857 @default.
• W2561872017 cites W2162965771 @default.
• W2561872017 cites W2165123465 @default.
• W2561872017 cites W2167454336 @default.
• W2561872017 cites W4321000917 @default.
• W2561872017 doi "https://doi.org/10.1158/1078-0432.ccr-16-1518" @default.
• W2561872017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27979915" @default.
• W2561872017 hasPublicationYear "2017" @default.
• W2561872017 type Work @default.
• W2561872017 sameAs 2561872017 @default.
• W2561872017 citedByCount "114" @default.
• W2561872017 countsByYear W25618720172017 @default.
• W2561872017 countsByYear W25618720172018 @default.
• W2561872017 countsByYear W25618720172019 @default.
• W2561872017 countsByYear W25618720172020 @default.
• W2561872017 countsByYear W25618720172021 @default.
• W2561872017 countsByYear W25618720172022 @default.
• W2561872017 countsByYear W25618720172023 @default.
• W2561872017 crossrefType "journal-article" @default.
• W2561872017 hasAuthorship W2561872017A5014173403 @default.
• W2561872017 hasAuthorship W2561872017A5018750805 @default.
• W2561872017 hasAuthorship W2561872017A5023082531 @default.
• W2561872017 hasAuthorship W2561872017A5037882003 @default.
• W2561872017 hasAuthorship W2561872017A5041131679 @default.
• W2561872017 hasAuthorship W2561872017A5042684673 @default.
• W2561872017 hasAuthorship W2561872017A5044330314 @default.
• W2561872017 hasAuthorship W2561872017A5048050785 @default.
• W2561872017 hasAuthorship W2561872017A5062213825 @default.
• W2561872017 hasAuthorship W2561872017A5068645990 @default.
• W2561872017 hasAuthorship W2561872017A5080598896 @default.
• W2561872017 hasAuthorship W2561872017A5081967247 @default.
• W2561872017 hasAuthorship W2561872017A5082853715 @default.
• W2561872017 hasAuthorship W2561872017A5088012470 @default.
• W2561872017 hasBestOaLocation W25618720171 @default.
• W2561872017 hasConcept C104317684 @default.
• W2561872017 hasConcept C108215921 @default.

• next